287
Views
21
CrossRef citations to date
0
Altmetric
Articles

Therapeutic benefit of mesenchymal stem cells in pregnant rats with angiotensin receptor agonistic autoantibody-induced hypertension: Implications for immunomodulation and cytoprotection

ORCID Icon, , , , , & show all
Pages 247-258 | Received 17 Jul 2016, Accepted 07 May 2017, Published online: 13 Jun 2017

References

  • Lain, KY and Roberts, JM. Contemporary Concepts of the Pathogenesis and Management of Preeclampsia, JAMA. 2002:287: 3183–3186.
  • Roberts, JM and Cooper, DW. Pathogenesis and Genetics of Preeclampsia, Lancet. 2007:357: 53–56.
  • Redman, CW and Sargent, IL. Latest Advances in Understanding Preeclampsia, Science. 2005:308: 1592–1594.
  • Gilbert, JS, Ryan, MJ, LaMarca, BB, Sedeek, M, Murphy, SR, and Granger JP. Pathophysiology of Hypertension during Preeclampsia: Linking Placental Ischemia with Endothelial Dysfunction, Am J Physiol Heart Circ Physiol. 2008:294: H541–H550.
  • Friedenstein, AJ, Chailakhyan, RK, Latsinik, NV, Panasyuk, AF, and Keiliss-Borok IV. Stromal Cells Responsible for Transferring the Microenvironment of the Hemopoietic Tissues, Transplantation. 1974:17: 331–340.
  • Owen, M and Friedenstein, AJ. Stromal Stem Cells: Marrow-derived Osteogenic Precursors. Ciba Found Symp. 1998:136: 42–60.
  • Prockop, DJ. Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues. Science, 1997:276: 71–74.
  • Meirelles Lda, S, Fontes, AM, Covas, DT, and Caplan, AI. Mechanisms Involved in the Therapeutic Properties of Mesenchymal Stem Cells, Cytokine Growth Factor Rev. 2009:20: 419–427.
  • Itakura, S, Asari, S, Rawson, J, Ito, T, Todorov, I, Liu, CP, Sasaki, N, Kandeel, F, and Mullen, Y. Mesenchymal Stem Cells Facilitate the Induction of Mixed Hematopoietic Chimerism and Islet Allograft Tolerance without GVHD in the Rat, Am J Transplant. 2007:7: 336–346.
  • Le Blanc, K, Rasmusson, I, Sundberg, B, Gotherstrom, C, Hassan, M, Uzune, M, and Ringden, O. Treatment of Severe Acute Graft-versus-host Disease with Third Party Haploidentical Mesenchymal Stem Cells, Lancet. 2004;363:1439–1441.
  • Ringdén, O, Uzunel, M, Rasmusson, I, Remberger, M, Sundberg, B, L?nnies, H, Marschall, HU, Dlugosz, A, Szakos, A, Hassan, Z et al. Mesenchymal Stem Cells for Treatment of Therapy Resistant Graft-versus-host Disease, Transplantation. 2008:81: 1390–1397.
  • Chabannes, D, Hill, M, Merieau, E, Rossignol, J, Brion, R, Soulillou, JP, Anegon, I, and Cuturi, MC. A Role for Heme Oxygenase-1 in the Immunosuppressive Effect of Adult Rat and Human Mesenchymal Stem Cells, Blood. 2007:110: 3691–3694.
  • Zhou, CC, Zhang, Y, Irani, RA, Zhang, H, Mi, T, Popek, EJ, Hicks, MJ, Ramin, SM, Kellems, RE, and Xia, Y. Angiotensin Receptor Agonistic Autoantibodies Induce Pre-eclampsia in Pregnant Mice, Nat Med. 2008:14: 855–862.
  • Mitchell, KE, Weiss, ML, Mitchell, BM, Martin, P, Davis, D, Morales, L, Helwig, B, Beerenstrauch, M, Abou-Easa, K, Hildreth T et al. Matrix Cells from Wharton’s Jelly Form Neurons And Glia, Stem Cells. 2003:21: 50–60.
  • Wang, HS, Hung, SC, Peng, ST, Huang, CC, Wei, HM, Guo, YJ, Fu, YS, Lai, MC, and Chen, CC. Mesenchymal Stem Cells in the Wharton’s Jelly of the Human Umbilical Cord, Stem Cells. 2004:22: 1330–1337.
  • Zhang, M, Zhang, BH, Chen, L, and An, W. Overexpression of Heme Oxygen-ase-1 Protects Smooth Muscle Cells against Oxidative Injury and Inhibits Cell Proliferation, Cell Res. 2002:12: 123–132.
  • Dechend, R, Homuth, V, Wallukat, G, Kreuzer, J, Park, JK, Theuer, J, Juepner, A, Gulba, DC, Mackman, N, Haller, H, and Luft, FC. AT(1) Receptor Agonistic Antibodies from Preeclamptic Patients Cause Vascular Cells to Express Tissue Factor, Circulation. 2000:101: 2382–2387.
  • Wallukat, G and Wollenberger, A. Effects of the Serum Gamma Globulin Fraction Of Patients with Allergic Asthma and Dilated Cardiomyopathy on Chronotropic β-adrenoceptor Function in Cultured Rat Heart Myocytes, Biomed Biochim Acta. 1987:78: 634–639.
  • Takimoto, E, Ishida, J, Sugiyama, F, Horiguchi, H, Murakami, K, and Fukamizu, A. Hypertension Induced in Pregnant Mice by Placental Renin and Maternal Angiotensinogen, Science. 1996:274: 995–958.
  • Livak, KJ and Schmittgen, TD. Analysis of Relative Gene Expression Data using Real-time Quantitative PCR and the 2(-delta Delta CT) Method, Methods. 2001:25: 402–408.
  • Caluwaerts, S, Vercruysse, L, Luyten, C, and Pijnenborg, R. Endovascular Trophoblast Invasion and Associated Structural Changes in Uterine Spiral Arteries of the Pregnant Rat, Placenta. 2005:26: 574–584.
  • Geusens, N, Verlohren, S, Luyten, C, Taube, M, Hering, L, Vercruysse, L, Hanssens, M, Dudenhausen, JW, Dechend, R, and Pijnenborg, R. Endovascular Trophoblast Invasion, Spiral Artery Remodelling and Uteroplacental Haemodynamics in a Transgenic Rat Model of Preeclampsia, Placenta. 2008:29: 614–623.
  • Muschler, GF, Nakamoto, C, and Griffith, LG. Engineering Principles of Clinical Cell-based Tissue Engineering, J Bone Joint Surg Am. 2004:86-A: 1541–1558.
  • Caplan, AI and Dennis, JE. Mesenchymal Stem Cells as Trophic Mediators, J Cell Biochem. 2006:98: 1076–1084.
  • Piccinni, MP, Scaletti, C, Maggi, E, and Romagnani S. Role of Hormone-controlled Th1- and Th2-type Cytokines in Successful Pregnancy, J Neuroimmunol. 2000:109: 30–33.
  • Benyo, DF, Smarason, A, Redman, CW, Sims, C, and Conrad, KP. Expression of Inflammatory Cytokines in Placentas from Women with Preeclampsia, J Clin Endocrinol Metab. 2001:86: 2505–2512.
  • Hennessy, A, Pilmore, HL, Simmons, LA, and Painter, DM. A Deficiency of Placental IL-10 in Preeclampsia, J Immunol. 1999:163: 3491–3495.
  • Makris, A, Xu, B, Yu, B, Thornton, C, and Hennessy, A. Placental Deficiency of Interleukin-10 (IL-10) in Preeclampsia and its Relationship to an IL10 Promoter Polymorphism, Placenta. 2006:27: 445–451.
  • Irani, RA, Zhang, Y, Zhou, CC, Blackwell, SC, Hicks, MJ, Ramin, SM, Kellems, RE, and Xia, Y. Autoantibody-mediated Angiotensin Receptor Activation Contributes to Preeclampsia through Tumor Necrosis Factor-α Signaling, Hypertension. 2010:55: 1246–1253.
  • Le Blanc, K, Rasmusson, I, Sundberg, B, Gotherstrom, C, Hassan, M, Uzunel, M, and Ringden, O. Treatment of Severe Acute Graft-versus-host Disease with Third Party Haploidentical Mesenchymal Stem Cells, Lancet. 2004:363: 1439–1441.
  • Nauta, AJ and Fibbe, WE. Immunomodulatory Properties of Mesenchymal Stromal Cells, Blood. 2007:110: 3499–3506.
  • Aggarwal, S and Pittenger, MF. Human Mesenchymal Stem Cells Modulate Allogeneic Immune Cell Responses, Blood. 2005:105: 1815–1822.
  • Woo, J, Iyer, S, Mori, N, and Buellow, R. Alleviation of Graft-versus-host Disease after Conditioning with Cobalt-protopor-phirin, an Inducer of Heme-oxigenase-1, Transplantation. 2000:69: 623–633.
  • Purcell, TL, Buhimschi, IA, Given, R, Chwalisz, K, and Garfield, RE. Inducible Nitric Oxide Synthase is Present in the Rat Placenta at the Fetal Maternal Interface and Decreases Prior to Labour, Mol Hum Reprod. 1997:3: 485–491.
  • Zhao, H, Wong, RJ, Kalish, FS, Nayak, NR, and Stevenson, DK. Effect of Heme Oxygenase-1deficiency of Placenta Development, Placenta. 2009:30: 861–868.
  • Parrish, MR, Wallace, K, Tam Tam, KB, Herse, F, Weimer, A, Wenzel, K, Wallukat, G, Ray, LF, Arany, M, Cockrell, K et al. Hypertension in Response to AT1-AA: Role of Reactive Oxygen Species in Pregnancy-induced Hypertension, Am J Hypertens. 2011:24: 835–840.
  • Lassegue, B and Griendling, KK. Reactive Oxygen Species in Hypertension: An Update, Am J Hypertens. 2004:17: 852–860.
  • Landmesser, U and Drexler, H. Endothelial Function and Hypertension, Curr Opin Cardiol. 2007:22: 316–320.
  • Kwak, JY, Takeshige, K, Cheung, BS, and Minakami, S. Bilirubin Inhibits the Activation of Superoxide-producing NADPH Oxidase in a Neutrophil Cell-free System, Biochim Biophys Acta. 1991:1076: 369–373.
  • Sano, K, Nakamura, H, and Matsuo, T. Mode of Inhibitory Action of Bilirubin on Protein Kinase C, Pediatr Res. 1985:19: 587–590.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.